Virtual ISPOR Europe 2020 is focused on Improving Health: Establishing Incentives and Sharing Value. Evidera is once again looking forward to participating at this meeting. With 50 presentations – including workshops, issue panels, podium, forum, and posters – addressing topics such as the impact of COVID-19 on clinical trials, patient preference, patient-reported outcomes (PROs), cost-effectiveness analyses, indirect treatment comparisons, and modeling and simulation, our thought leaders are speaking to important and relevant topics affecting our industry.
Cost-Effectiveness Modelling of Complex Pathways
Is Population Adjustment Enough to Reduce Bias in Unanchored Comparisons of Progression-Free Survival in Oncology? The Importance of Dealing with Progression Assessment Time Differences
Patients' Preferences for Once-Daily Oral Versus Once-Weekly Injectable Diabetes Medications: The REVISE Study
Integrating Patient Preference into Health Technology Assessment: Can Patient Preferences be Incorporated into the ICER?
The Meaning of Cure - the Search for What?